Please login to the form below

Not currently logged in
Email:
Password:

KKR

This page shows the latest KKR news and features for those working in and with pharma, biotech and healthcare.

Investment firm pays $2.8bn for WebMD

Investment firm pays $2.8bn for WebMD

Investment firm pays $2.8bn for WebMD. The online health information portal will join KKR's Internet Brands subsidiary. ... KKR will roll WebMD into its Internet Brands subsidiary, a leading web hosting and software-as-a-service (SaaS) company that works

Latest news

  • Bayer sells diabetes division to Panasonic Healthcare Bayer sells diabetes division to Panasonic Healthcare

    Sales of the divested products lines were 909m last year, and Panasonic - which is majority-owned by private equity group KKR - says gaining full control will allow it to improve growth ... We are confident that the sale of our diabetes-care business to

  • GSK plans to sell off older products GSK plans to sell off older products

    conference. Among the firms given the opportunity to view the portfolio are Advent International, Blackstone and KKR, according to Reuters, which indicated the overture was initially revealed by Sky News.

  • KKR acquires clinical trials firm PRA International

    US clinical research organisation (CRO) PRA International has been acquired for an undisclosed sum by global investment firm KKR. “ ... KKR has a long history in healthcare, having invested more than $9bn in the sector since 1995.

  • Capsugel expands its product portfolio

    The New Jersey company, which Pfizer sold for $2.4bn in 2011 to investment firm KKR, has announced the launched of its Dosage Form Solutions (DFS) unit.

  • Major pharma deals during 2011

    There have been a few examples of this including Pfizer's $2.4bn divestment of its Capsugel Business to KKR in April, as well as its divestment of an Irish biologics

More from news
Approximately 2 fully matching, plus 11 partially matching documents found.

Latest Intelligence

  • Deal Watch - May 2017 Deal Watch - May 2017

    Barbarians at the Gate. “Barbarians at the Gate”is the title of a book describing the battle for control of RJR Nabisco in 1988 between KKR, a leveraged buyout firm (“LBO”), ... KKR won the battle and were accused of being Barbarians for loading

  • Deal Watch table for September 2013 Deal Watch table for September 2013

    700. Gland Pharma / KKR. Acquisition (40 per cent). Indian generics company.

  • Pharma deals during September 2013 Pharma deals during September 2013

    Similar concerns are faced by Indian authorities as KKR has announced its intention to acquire 40 pre cent of generics company Gland Pharma for around $500m.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...
Light_bulb_Stock_Market.jpg
Creativity has lost its worth
Creativity has lost its worth, and sadly it is undermining effectiveness...

Infographics